story of the week
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- 2018 Top Stories in Benign Hematology: The Era of Personalized Treatment of Myeloid Neoplasms: Bringing Genomics to the Bedside
- Sequential Mutational Evaluation of CALR -Mutated Myeloproliferative Neoplasms With Thrombocytosis Reveals an Association Between CALR Allele Burden Evolution and Disease Progression
- Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia and Polycythemia Vera
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
N. Engl. J. Med 2018 Oct 11;379(15)1416-1430, J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, AL Godfrey, E Papaemmanuil, G Gundem, C MacLean, J Cook, L O'Neil, S O'Meara, JW Teague, AP Butler, CE Massie, N Williams, FL Nice, CL Andersen, HC Hasselbalch, P Guglielmelli, MF McMullin, AM Vannucchi, CN Harrison, M Gerstung, AR Green, PJ CampbellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.